Internal Medicine · Greensboro, NC
NPI
1972598654
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1511 Westover Ter, Suite 201
Greensboro, NC, 27408
Phone (336) 373-0611
Groups this clinician bills Medicare through
Medicare paid, 2024
$199K
5,724 services
Medicare patients, 2024
259
Average age 78
Drug cost, 2024
$1.6M
15,303 prescriptions
Company payments, 2025
$2,460
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walter D Pharr was code J0897 (injection, denosumab, 1 mg), 3,900 times for 39 patients. In total Walter D Pharr billed 5,724 services in 60 codes, and Medicare paid $199K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,900 | 39 | $20.42 | $80K |
| 99214 Office E&M - Established | Office | 335 | 217 | $82.89 | $28K |
| 99213 Office E&M - Established | Office | 299 | 144 | $58.87 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 206 | 206 | $121.29 | $25K |
| G0008 Administration of influenza virus vaccine | Office | 77 | 77 | $30.39 | $2,340 |
| 90673 Vaccine Product | Office | 74 | 74 | $81.82 | $6,055 |
| 96372 Injection Administration | Office | 73 | 41 | $10.49 | $765 |
| 93000 Electrocardiogram | Office | 69 | 68 | $9.27 | $639 |
| 90677 Vaccine Product | Office | 48 | 48 | $288.63 | $14K |
| G0009 Administration of pneumococcal vaccine | Office | 48 | 48 | $30.39 | $1,459 |
| 83036 Blood Count | Office | 46 | 30 | $9.52 | $438 |
| 91320 Vaccine Product | Office | 39 | 39 | $146.55 | $5,715 |
| 90480 Vaccine Administration | Office | 38 | 38 | $40.52 | $1,540 |
| 77080 Standard X-ray | Office | 33 | 33 | $35.58 | $1,174 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 30 | 22 | $36.28 | $1,089 |
By year: 2022 $269K for 9,492 services; 2023 $225K for 9,329 services; 2024 $199K for 5,724 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 46 | 30 | $9.52 | $438 |
Medicare prescription drug claims, 2024
In 2024, the drug Walter D Pharr prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,242 prescriptions and refills. In total Walter D Pharr wrote 15,303 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,242 | 3,455 | 350 | $18K |
| Atorvastatin Calcium Generic | 758 | 2,011 | 190 | $9,437 |
| Amlodipine Besylate Generic | 646 | 1,636 | 159 | $4,370 |
| Levothyroxine Sodium Generic | 603 | 1,434 | 140 | $7,235 |
| Pantoprazole Sodium Generic | 480 | 1,188 | 131 | $8,350 |
| Losartan Potassium Generic | 450 | 1,258 | 124 | $5,420 |
| Ezetimibe Generic | 402 | 1,103 | 118 | $7,355 |
| Sertraline Hcl Generic | 340 | 907 | 98 | $3,572 |
| Omeprazole Generic | 275 | 790 | 84 | $5,488 |
| Gabapentin Generic | 261 | 465 | 67 | $4,284 |
| Metoprolol Succinate Generic | 246 | 706 | 74 | $4,223 |
| Trazodone Hcl Generic | 245 | 482 | 67 | $1,921 |
| Bupropion Xl Bupropion Hcl | 237 | 487 | 66 | $5,472 |
| Metformin Hcl Er Metformin Hcl | 236 | 655 | 69 | $2,631 |
| Olmesartan Medoxomil Generic | 234 | 609 | 68 | $3,798 |
Brand drugs: 2,279 claims; generic drugs: 12,938 claims; opioid claims: 186.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walter D Pharr $2,460 ($2,460 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $382.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $382 |
| UCB, Inc. UCB.BR | 21 | $373 |
| Amgen Inc. AMGN | 34 | $366 |
| Mallinckrodt Hospital Products Inc. | 12 | $251 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $247 |
| Janssen Biotech, Inc. JNJ | 8 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $150 |
| GlaxoSmithKline, LLC. GSK | 10 | $138 |
| Radius Health, Inc. | 3 | $62.81 |
| Dexcom, Inc. DXCM | 3 | $50.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.